Frontmatter

Startseite Frontmatter

Artikel Öffentlich zugänglich

Veröffentlicht/Copyright: 10. Juni 2016

Veröffentlicht von

Veröffentlichen auch Sie bei De Gruyter Brill

Manuskript einreichen Informationen für Autor*innen

"Frontmatter" Drug Metabolism and Personalized Therapy, vol. 31, no. 2, 2016, pp. i-iii. https://doi.org/10.1515/dmpt-2016-frontmatter2

(2016). Frontmatter. Drug Metabolism and Personalized Therapy, 31(2), i-iii. https://doi.org/10.1515/dmpt-2016-frontmatter2

(2016) Frontmatter. Drug Metabolism and Personalized Therapy, Vol. 31 (Issue 2), pp. i-iii. https://doi.org/10.1515/dmpt-2016-frontmatter2

"Frontmatter" Drug Metabolism and Personalized Therapy 31, no. 2 (2016): i-iii. https://doi.org/10.1515/dmpt-2016-frontmatter2

Frontmatter. Drug Metabolism and Personalized Therapy. 2016;31(2): i-iii. https://doi.org/10.1515/dmpt-2016-frontmatter2

In die Zwischenablage kopiert

Published Online: 2016-6-10

Published in Print: 2016-6-1

Artikel in diesem Heft

Frontmatter
In Memoriam Gérard Siest
Reviews
Interethnic variability of pharmacogenetic biomarkers in Mexican healthy volunteers: a report from the RIBEF (Ibero-American Network of Pharmacogenetics and Pharmacogenomics)
Predictive biomarkers candidates for patients with metastatic colorectal cancer treated with bevacizumab-containing regimen
Mini Reviews
The integration and interpretation of pharmacogenomics – a comparative study between the United States of America and Europe: towards better health care
Investigating the impact of missense mutations in hCES1 by in silico structure-based approaches
Original Articles
Lack of genomic diversity in the SLC47A1 gene within the indigenous Xhosa population
Assessment of cytochrome P450 inhibition and induction potential of lupeol and betulin in rat liver microsomes
Altered pharmacokinetics and pharmacodynamics of repaglinide by ritonavir in rats with healthy, diabetic and impaired hepatic function

Zeitschrift durchsuchen In dieser Zeitschrift suchen

Frontmatter
In Memoriam Gérard Siest
Reviews
Interethnic variability of pharmacogenetic biomarkers in Mexican healthy volunteers: a report from the RIBEF (Ibero-American Network of Pharmacogenetics and Pharmacogenomics)
Predictive biomarkers candidates for patients with metastatic colorectal cancer treated with bevacizumab-containing regimen
Mini Reviews
The integration and interpretation of pharmacogenomics – a comparative study between the United States of America and Europe: towards better health care
Investigating the impact of missense mutations in hCES1 by in silico structure-based approaches
Original Articles
Lack of genomic diversity in the SLC47A1 gene within the indigenous Xhosa population
Assessment of cytochrome P450 inhibition and induction potential of lupeol and betulin in rat liver microsomes
Altered pharmacokinetics and pharmacodynamics of repaglinide by ritonavir in rats with healthy, diabetic and impaired hepatic function